We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Cariprazine Relative to Placebo in the Prevention of Relapse of Symptoms in Patients With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01412060
Recruitment Status : Completed
First Posted : August 8, 2011
Last Update Posted : September 30, 2015
Gedeon Richter Ltd.
Information provided by (Responsible Party):
Forest Laboratories

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : August 2014
  Study Completion Date : November 2014
  Certification or Request for Extension to Delay Results Submission: September 25, 2015